IBDEI0CF ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16647,2)
 ;;=Heart Failure, Acute Diastolic^328497
 ;;^UTILITY(U,$J,358.3,16648,0)
 ;;=428.32^^88^927^43
 ;;^UTILITY(U,$J,358.3,16648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16648,1,4,0)
 ;;=4^428.32
 ;;^UTILITY(U,$J,358.3,16648,1,5,0)
 ;;=5^Heart Failure, Chronic Diastolic
 ;;^UTILITY(U,$J,358.3,16648,2)
 ;;=Heart Failure, Chronic Diastolic^328498
 ;;^UTILITY(U,$J,358.3,16649,0)
 ;;=428.33^^88^927^47
 ;;^UTILITY(U,$J,358.3,16649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16649,1,4,0)
 ;;=4^428.33
 ;;^UTILITY(U,$J,358.3,16649,1,5,0)
 ;;=5^Heart Failure, Diastolic, Acute on Chronic
 ;;^UTILITY(U,$J,358.3,16649,2)
 ;;=Heart Failure, Diastolic, Acute on Chronic^328499
 ;;^UTILITY(U,$J,358.3,16650,0)
 ;;=428.40^^88^927^46
 ;;^UTILITY(U,$J,358.3,16650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16650,1,4,0)
 ;;=4^428.40
 ;;^UTILITY(U,$J,358.3,16650,1,5,0)
 ;;=5^Heart Failure, Diastolic& Systolic
 ;;^UTILITY(U,$J,358.3,16650,2)
 ;;=Heart Failure, Systolic and Diastolic^328596
 ;;^UTILITY(U,$J,358.3,16651,0)
 ;;=428.41^^88^927^48
 ;;^UTILITY(U,$J,358.3,16651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16651,1,4,0)
 ;;=4^428.41
 ;;^UTILITY(U,$J,358.3,16651,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute
 ;;^UTILITY(U,$J,358.3,16651,2)
 ;;=Heart Failure, Systolic & Diastolic, Acute^328500
 ;;^UTILITY(U,$J,358.3,16652,0)
 ;;=428.42^^88^927^52
 ;;^UTILITY(U,$J,358.3,16652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16652,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,16652,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,16652,2)
 ;;=^328501
 ;;^UTILITY(U,$J,358.3,16653,0)
 ;;=428.43^^88^927^51
 ;;^UTILITY(U,$J,358.3,16653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16653,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,16653,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic
 ;;^UTILITY(U,$J,358.3,16653,2)
 ;;=^328502
 ;;^UTILITY(U,$J,358.3,16654,0)
 ;;=396.3^^88^927^10
 ;;^UTILITY(U,$J,358.3,16654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16654,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,16654,1,5,0)
 ;;=5^Aortic and Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,16654,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,16655,0)
 ;;=429.9^^88^927^28
 ;;^UTILITY(U,$J,358.3,16655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16655,1,4,0)
 ;;=4^429.9
 ;;^UTILITY(U,$J,358.3,16655,1,5,0)
 ;;=5^Diastolic Dysfunction
 ;;^UTILITY(U,$J,358.3,16655,2)
 ;;=^54741
 ;;^UTILITY(U,$J,358.3,16656,0)
 ;;=453.79^^88^927^27
 ;;^UTILITY(U,$J,358.3,16656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16656,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,16656,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,16656,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,16657,0)
 ;;=453.89^^88^927^1
 ;;^UTILITY(U,$J,358.3,16657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16657,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,16657,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,16657,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,16658,0)
 ;;=454.2^^88^927^85
 ;;^UTILITY(U,$J,358.3,16658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16658,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,16658,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,16658,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,16659,0)
 ;;=397.1^^88^927^74
 ;;^UTILITY(U,$J,358.3,16659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16659,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,16659,1,5,0)
 ;;=5^Rheumatic Disease Pulmonary Valve
 ;;^UTILITY(U,$J,358.3,16659,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,16660,0)
 ;;=397.0^^88^927^75
 ;;^UTILITY(U,$J,358.3,16660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16660,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,16660,1,5,0)
 ;;=5^Rheumatic Disease Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,16660,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,16661,0)
 ;;=414.3^^88^927^17
 ;;^UTILITY(U,$J,358.3,16661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16661,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,16661,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,16661,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,16662,0)
 ;;=414.4^^88^927^16
 ;;^UTILITY(U,$J,358.3,16662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16662,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,16662,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,16662,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,16663,0)
 ;;=425.11^^88^927^60
 ;;^UTILITY(U,$J,358.3,16663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16663,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,16663,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,16663,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,16664,0)
 ;;=425.18^^88^927^59
 ;;^UTILITY(U,$J,358.3,16664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16664,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,16664,1,5,0)
 ;;=5^Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,16664,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,16665,0)
 ;;=V12.55^^88^927^54
 ;;^UTILITY(U,$J,358.3,16665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16665,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,16665,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,16665,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,16666,0)
 ;;=454.9^^88^927^84
 ;;^UTILITY(U,$J,358.3,16666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16666,1,4,0)
 ;;=4^454.9
 ;;^UTILITY(U,$J,358.3,16666,1,5,0)
 ;;=5^Varicose Veins
 ;;^UTILITY(U,$J,358.3,16666,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,16667,0)
 ;;=271.3^^88^928^11
 ;;^UTILITY(U,$J,358.3,16667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16667,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,16667,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,16667,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,16668,0)
 ;;=611.1^^88^928^16
 ;;^UTILITY(U,$J,358.3,16668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16668,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,16668,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,16668,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,16669,0)
 ;;=704.1^^88^928^17
 ;;^UTILITY(U,$J,358.3,16669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16669,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,16669,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,16669,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,16670,0)
 ;;=251.2^^88^928^30
 ;;^UTILITY(U,$J,358.3,16670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16670,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,16670,1,5,0)
 ;;=5^Hypoglycemia NOS
 ;;^UTILITY(U,$J,358.3,16670,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,16671,0)
 ;;=253.2^^88^928^34
 ;;^UTILITY(U,$J,358.3,16671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16671,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,16671,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,16671,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,16672,0)
 ;;=733.00^^88^928^43
 ;;^UTILITY(U,$J,358.3,16672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16672,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,16672,1,5,0)
 ;;=5^Osteoporosis NOS
 ;;^UTILITY(U,$J,358.3,16672,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,16673,0)
 ;;=278.00^^88^928^40
 ;;^UTILITY(U,$J,358.3,16673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16673,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,16673,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,16673,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,16674,0)
 ;;=278.01^^88^928^39
 ;;^UTILITY(U,$J,358.3,16674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16674,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,16674,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,16674,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,16675,0)
 ;;=250.80^^88^928^10
 ;;^UTILITY(U,$J,358.3,16675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16675,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,16675,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,16675,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,16676,0)
 ;;=250.00^^88^928^5
 ;;^UTILITY(U,$J,358.3,16676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16676,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,16676,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,16676,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,16677,0)
 ;;=250.40^^88^928^6
 ;;^UTILITY(U,$J,358.3,16677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16677,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,16677,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,16677,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,16678,0)
 ;;=250.50^^88^928^9
 ;;^UTILITY(U,$J,358.3,16678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16678,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,16678,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,16678,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,16679,0)
 ;;=250.60^^88^928^7
 ;;^UTILITY(U,$J,358.3,16679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16679,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,16679,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,16679,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,16680,0)
 ;;=250.70^^88^928^8
 ;;^UTILITY(U,$J,358.3,16680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16680,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,16680,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,16680,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,16681,0)
 ;;=250.01^^88^928^4
 ;;^UTILITY(U,$J,358.3,16681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16681,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,16681,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,16681,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,16682,0)
 ;;=272.0^^88^928^22
 ;;^UTILITY(U,$J,358.3,16682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16682,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,16682,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,16682,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,16683,0)
 ;;=272.1^^88^928^28
 ;;^UTILITY(U,$J,358.3,16683,1,0)
 ;;=^358.31IA^5^2
